Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/08/2012 | US8173435 Method for evaluating oil-and-fat amount in seed and method for screening for plant exhibiting varied level of oil-and-fat content |
05/08/2012 | US8173434 PCan065 antibody compositions and methods of use |
05/08/2012 | US8173433 Platelet biomarkers for cancer |
05/08/2012 | US8173432 Method and system for characterization and mapping of tissue lesions |
05/08/2012 | US8173431 Mail screening to detect mail contaminated with biological harmful substances |
05/08/2012 | US8173430 Simulant material and method for manufacture thereof |
05/08/2012 | US8173384 Methods for analyzing or processing a heparin sample |
05/08/2012 | US8173383 Methods and materials for the detection of Leishmania infection |
05/08/2012 | US8173382 Assay for cardiac troponin autoantibodies |
05/08/2012 | US8173381 Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer |
05/08/2012 | US8173380 Metering technique for lateral flow assay devices |
05/08/2012 | US8173379 Method of determining a concentration of analytes of interest in a sample |
05/08/2012 | US8173378 Methods of using an alpha-1-adrenergic receptor having altered ligand affinity |
05/08/2012 | US8173377 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
05/08/2012 | US8173376 Method for identifying compounds for treatment of pain |
05/08/2012 | US8173375 Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same |
05/08/2012 | US8173374 Human embryonic stem cell methods and PODXL expression |
05/08/2012 | US8173373 Methods of screening T1R1/T1R3 heteromeric receptors for compounds that modulate umami taste signaling |
05/08/2012 | US8173372 Methods of donor specific crossmatching |
05/08/2012 | US8173369 Peripheral gene expression biomarkers for autism |
05/08/2012 | US8173365 Method for inhibiting signal transduction, signal transduction inhibitor to be used therein and use thereof |
05/08/2012 | US8173363 Random transposon insertion in Staphylococcus aureus and use thereof to identify essential genes |
05/08/2012 | US8173361 Method of determining metabolism of a test agent |
05/08/2012 | US8173360 Cell death inhibitor |
05/08/2012 | US8173359 Methods and apparatus and assays of bacterial spores |
05/08/2012 | US8173188 Method of controlling heating cooking apparatus |
05/08/2012 | US8173123 Methods of treating colitis involving IL-13 and NK-T cells |
05/08/2012 | US8173121 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
05/08/2012 | US8173117 Mouse CX3C chemokine polypeptides |
05/08/2012 | US8173105 Contrast agents and methods for preparing contrast agents |
05/08/2012 | US8173079 Method for forming structured polymeric film |
05/08/2012 | US8173069 Ion analyzing apparatus and ion analyzing method |
05/08/2012 | US8173068 Fluid exchange in a chamber on a microscope slide |
05/08/2012 | US8173008 Method for determining an analyte in a bodily fluid sample using an analyte test strip with combination electrode contact and meter identification feature |
05/08/2012 | US8172994 Biomaterial measuring device and manufacturing method thereof |
05/08/2012 | US8172545 Method for controlling ground meat flow rates |
05/08/2012 | CA2623339C Virulence genes in the vgc2 cluster of salmonella |
05/08/2012 | CA2612693C Quantitative assays for ras p21 in body fluids |
05/08/2012 | CA2579254C Enhanced stability of proteins immobilized on nanoparticles |
05/08/2012 | CA2576902C Method and device for detecting feline immunodeficiency virus |
05/08/2012 | CA2540156C Apparatus and methods for selecting capacitated spermatozoa and uses thereof |
05/08/2012 | CA2533355C Electrochemical sensor |
05/08/2012 | CA2516570C Gas monitoring system and sidestream gas measurement system adapted to communicate with a mainstream gas measurement system |
05/08/2012 | CA2493101C Impedance based apparatuses and methods for analyzing cells and particles |
05/08/2012 | CA2459211C Products containing quantum of bioparticles and method for production thereof |
05/08/2012 | CA2411842C A protein fragment complementation assay utilizing e.coli tem-1 .beta.-lactamase |
05/08/2012 | CA2362264C Cytokine-binding domain |
05/08/2012 | CA2249303C Chromatographic immunoassay device and method utilizing particle valency for quantitation |
05/08/2012 | CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
05/08/2012 | CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
05/08/2012 | CA1341629C Hepatitis c diagnostics and vaccines |
05/05/2012 | CA2811712A1 Systems and methods for improved stability of electrochemical sensors |
05/04/2012 | DE202012003813U1 Pulverlack-Testvorrichtung Powder coating test device |
05/03/2012 | WO2012058667A2 Cancer diagnosis by enhanced telomerase activity |
05/03/2012 | WO2012058665A1 Compositions and methods for modulation and detection of immune and inflammatory responses |
05/03/2012 | WO2012058642A2 Use of sam68 for modulating signaling through the tnf receptor |
05/03/2012 | WO2012058637A2 Antisera assays for mlv related viruses in humans and other mammals |
05/03/2012 | WO2012058630A2 A method to generate novel bioactive molecules |
05/03/2012 | WO2012058627A2 Pre-targeted nanoparticle system and method for labeling biological particles |
05/03/2012 | WO2012058619A1 Lc-ms configuration for purification and detection of analytes having a broad range of hydrophobicities |
05/03/2012 | WO2012058614A1 Lc-ms separation and detection of vitamin d metabolites |
05/03/2012 | WO2012058545A2 Process for analyzing and establishing dosage size in an ingestible film |
05/03/2012 | WO2012058522A2 Cancer imaging with therapy: theranostics |
05/03/2012 | WO2012058464A2 Multiphasic polymeric particles capable of shape-shifting via environmental stimulation |
05/03/2012 | WO2012058334A1 Morphology & protein specific reagents as diagnostics for neurodegenerative diseases |
05/03/2012 | WO2012058316A1 Non-invasive fetal genetic screening by sequencing analysis |
05/03/2012 | WO2012058313A2 Novel biomarkers for cardiovascular injury |
05/03/2012 | WO2012058237A1 Analyte measurement devices and systems, and components and methods related thereto |
05/03/2012 | WO2012058201A2 Method for determining activators of excitatory synapse formation |
05/03/2012 | WO2012057904A1 Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity |
05/03/2012 | WO2012057878A1 Microfluidic processing of target species in ferrofluids |
05/03/2012 | WO2012057786A1 Oxygen measuring apparatuses |
05/03/2012 | WO2012057712A2 On-chip laboratory for blood analysis |
05/03/2012 | WO2012057706A1 Method for micropatterning a substrate and a patterned substrate formed thereof |
05/03/2012 | WO2012057697A1 New diagnostic and therapeutic target |
05/03/2012 | WO2012057689A1 Proximity ligation technology for western blot applications |
05/03/2012 | WO2012057681A1 Systems and methods for detection and imaging of two-dimensional sample arrays |
05/03/2012 | WO2012057670A1 Individualized prevention of dental caries |
05/03/2012 | WO2012057609A1 Process for the preparation of amoebocyte lysate from the haemolymph of the horseshoe crab |
05/03/2012 | WO2012057567A2 Kit for screening for skin-activating substances and comprising the klotho gene, and method for screening for skin-activating substances using same |
05/03/2012 | WO2012057548A2 Automatic real-time pcr system for the various analysis of biological smaple |
05/03/2012 | WO2012057473A2 Method for evaluating the improvement of skin elasticity using a mimetic dermis |
05/03/2012 | WO2012057401A1 Iron oxide nanoparticles in which gluconic acid and non-polymerized biological material are introduced as surface modifier, securing improved biocompatibility by optimum introduction of gluconic acid, and composition for diagnosing and treating cancer, containing same |
05/03/2012 | WO2012057294A1 Method for treating malaria, method for killing malaria parasite, and use of the methods |
05/03/2012 | WO2012056811A1 Method for selecting fungus body and kit |
05/03/2012 | WO2012056793A1 Deboning method and deboning apparatus of bony chops with x-rays |
05/03/2012 | WO2012056729A1 Sampling apparatus |
05/03/2012 | WO2012056706A1 Vital information measurement device and vital information measurement method employing same |
05/03/2012 | WO2012056641A1 Virus detection device and virus detection method |
05/03/2012 | WO2012056628A1 Living specimen measurement device |
05/03/2012 | WO2012056300A2 Real-time monitor solid phase peptide synthesis by mass spectrometry |
05/03/2012 | WO2012056233A1 Coated beads |
05/03/2012 | WO2012056232A1 Biomarkers |
05/03/2012 | WO2012056192A1 Preparation and analysis of samples in micro-/nano-fluidic devices |
05/03/2012 | WO2012056048A1 Treatment of inflammation |
05/03/2012 | WO2012056008A1 Diagnosis and treatment of alzheimer's disease |
05/03/2012 | WO2012055987A1 Novel drug target site within gp120 of hiv |
05/03/2012 | WO2012055879A1 Method of treatment by inhibition of baz1b |
05/03/2012 | WO2012055849A1 Sflt1 and pulmonary complications |
05/03/2012 | WO2012055828A1 Method of determining risk of arrythmia |